ReviewJournal of clinical medicine2024

Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients' Unmet Needs and Exploring Future Applications.

Ylenia Ingrasciotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.